FBRX FORTE BIOSCIENCES INC Capital Structure Changes 8-K Filing 2024 - Stock Split Approved Forte Biosciences' stockholders approved an amendment to the 2021 Equity Incentive Plan and a reverse stock split at a ratio of 1-for-25, effective August 28, 2024, with 36.5 million shares outstanding and 28.9 million shares represented at the annual meeting.Get access to all SEC 8-K filings of the FORTE BIOSCIENCES INC